Platelet Biotechnologies is awarded the Technology-based Companies funding program (Phase I) for the project “Development and validation of new generation platelet-derived bioproducts”

The goal of this project is to develop a business plan and strategize the viability of the project from a technical and commercial aspect.

Funding agency: Asturian Science, Business Competitiveness and Innovation Agency (Sekuens).